G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1)
TL;DR: Examination of effects of enantiomers of verapamil on digoxin transport across an LLC-PK1 cell monolayer, a model of proximal renal tubular cells, indicates that verAPamil inhibition ofdigoxin transport is non-stereospecific and the verapAmil-digoxin interaction is not competitive.
Journal Article
Complications resulting from use of arterial catheters: retrograde flow and rapid elevation in blood pressure.
TL;DR: In this article, retrograde blood flow occurring during routine flushing of peripheral and umbilical catheters is described, which is associated with a significant elevation of blood pressure at distant sites.
Journal ArticleDOI
Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.
TL;DR: This case has important implications for rheumatologists treating women of reproductive age, as the assumption of fetal safety of MTX, implied from small cohorts, is premature.
Journal Article
Nausea and vomiting of pregnancy. Evidence-based treatment algorithm.
Zina Levichek,Gardana Atanackovic,Dick Oepkes,Carolyn Maltepe,Adrienne Einarson,Laura A. Magee,Gideon Koren +6 more
TL;DR: An algorithm used by Motherisk to manage thousands of patients takes a hierarchical approach to this condition, which is evidence based with regard to fetal safety as well as efficacy.
Journal ArticleDOI
Noninvasive methods for drug measurement in pediatrics
TL;DR: In the past two decades, several new noninvasive methods to measure drugs have been tested and implemented in therapeutic drug monitoring and it is hoped that these new techniques will help advance the ability to diagnose and manage infants and young children.